Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2teRp2b
via IFTTT